Platelet reactivity linked to risks in endovascular procedures

05/1/2013 | Healio

A study in the Journal of the American College of Cardiology found that increased on-treatment platelet reactivity was tied to a greater risk of adverse clinical events with peripheral endovascular procedures. Basing antiplatelet treatment levels on point-of-care tests could lead to better outcomes for patients, the authors said.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY